Publicacións en colaboración con investigadores/as de University of Genoa (18)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score

    Neurology, Vol. 98, Núm. 5, pp. E518-E532

  2. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151

  3. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: An ERACODA registry analysis

    Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2308-2320

2020

  1. COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration

    Nephrology Dialysis Transplantation, Vol. 35, Núm. 11, pp. 1973-1983

2019

  1. Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5p15.33 TERT-CLPTM1Ll Region

    Journal of Thoracic Oncology, Vol. 14, Núm. 8, pp. 1360-1369

  2. Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: Data from the E-HOD registry

    Journal of Inherited Metabolic Disease, Vol. 42, Núm. 2, pp. 333-352

2018

  1. European Surveillance System on Contact Allergies (ESSCA): polysensitization, 2009–2014

    Contact Dermatitis, Vol. 78, Núm. 6, pp. 373-385

  2. Research update for articles published in EJCI in 2016

    European Journal of Clinical Investigation, Vol. 48, Núm. 10

2017

  1. A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

    American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74

  2. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 4, pp. 639-646

  3. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency

    Journal of Inherited Metabolic Disease, Vol. 40, Núm. 1, pp. 21-48

  4. Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2359-2367

2015

  1. Clinical profile of patients with ATP1A3 mutations in Alternating Hemiplegia of Childhood - A study of 155 patients

    Orphanet Journal of Rare Diseases, Vol. 10, Núm. 1

  2. Endotoxin-induced lung alveolar cell injury causes brain cell damage

    Experimental Biology and Medicine, Vol. 240, Núm. 1, pp. 135-142

2013

  1. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: A retrospective study

    Pediatrics, Vol. 131, Núm. 6

2012

  1. EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy

    Clinical and Translational Allergy, Vol. 2, Núm. 1